Abstract

To shed light on the discrepancy between reported binding and functional affinity and selectivity at α 1b/B-adrenoceptors, the antagonist (+)-cyclazosin was reinvestigated in rat and rabbit tissues. It displayed a competitive antagonism at α 1A and α 1D-adrenoceptors of rat prostatic vas deferens and aorta with p A 2 values 7.75 and 7.27, respectively. In rabbit thoracic aorta (+)-cyclazosin competitively antagonized noradrenaline-induced contractions at α 1B-adrenoceptors with a p A 2 value of 8.85, whereas its affinity at α 1L-adrenoceptors was markedly lower (p A 2 = 6.75 − 7.09). In conclusion, these data confirmed that (+)-cyclazosin is a selective α 1B-adrenoceptor antagonist also in functional assays, showing 13- and 38-fold selectivity for the α 1B-adrenoceptor over α 1A- and α 1D-subtypes, respectively. Furthermore, (+)-cyclazosin displayed a significant selectivity for α 1B-adrenoceptors relative to the α 1L-subtype.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call